Shopping Cart 0
Cart Subtotal
AED 0

Consort Medical plc (CSRT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

Consort Medical plc (Consort Medical) is a contract development and manufacturing organization (CDMO) with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostics. It offers metered dose inhalers, dry powder devices, actuators, dose counters, disposable auto-injectors, nasal devices and POC diagnostic devices. The company provides inhaler and auto-injector technologies and manufacturing services to pharmaceutical manufacturers; and active pharmaceutical ingredients (API), and finished dose formulation and manufacturing services. The company offers its products to pharmaceutical companies in the US, Europe, and other parts of the world through its subsidiaries and distributors. Consort Medical is headquartered in Hertfordshire, England, the UK.

Consort Medical plc (CSRT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Consort Medical plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Consort Medical plc, Medical Devices Deals, 2012 to YTD 2018 9

Consort Medical plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Consort Medical plc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Precision Ocular Raises USD20.5 Million in Series A Financing 11

Precision Ocular Raises USD19.4 Million in Venture Financing 13

Partnerships 15

SteadyMed Therapeutics Enters into Co-Development Agreement with Bespak 15

Aesica Enters Into Co-Development Agreement With University Of Nottingham For Amide Bond Synthesis 16

Licensing Agreements 17

Consort Medical Enter into Development Agreement with Opiant Pharma 17

Equity Offering 18

Consort Medical Raises USD160.6 Million in Rights Issue of Shares 18

Acquisition 20

Consort Medical Acquires Aesica Holdco for USD378.5 million 20

Consort Medical plc-Key Competitors 21

Consort Medical plc-Key Employees 22

Consort Medical plc-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 25

Financial Announcements 25

Jun 14, 2018: Consort Medical delivered another year of good growth in revenue and profit 25

Dec 05, 2017: Consort Medical: Interim results 28

Jun 15, 2017: Consort Medical: Full year results 29

Corporate Communications 30

Nov 06, 2018: Consort Medical announces its board change 30

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31


List Of Figure

List of Figures

Consort Medical plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Consort Medical plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Consort Medical plc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Consort Medical plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Consort Medical plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Consort Medical plc, Deals By Therapy Area, 2012 to YTD 2018 8

Consort Medical plc, Medical Devices Deals, 2012 to YTD 2018 9

Consort Medical plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Precision Ocular Raises USD20.5 Million in Series A Financing 11

Precision Ocular Raises USD19.4 Million in Venture Financing 13

SteadyMed Therapeutics Enters into Co-Development Agreement with Bespak 15

Aesica Enters Into Co-Development Agreement With University Of Nottingham For Amide Bond Synthesis 16

Consort Medical Enter into Development Agreement with Opiant Pharma 17

Consort Medical Raises USD160.6 Million in Rights Issue of Shares 18

Consort Medical Acquires Aesica Holdco for USD378.5 million 20

Consort Medical plc, Key Competitors 21

Consort Medical plc, Key Employees 22

Consort Medical plc, Other Locations 23

Consort Medical plc, Subsidiaries 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Consort Medical plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Consort Medical plc (Consort Medical) is a contract development and manufacturing organization (CDMO) with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostics. It offers metered dose inhalers, dry powder devices, actuators, dose counters, disposable auto-injectors, nasal devices and POC diagnostic devices. The company provides inhaler and auto-injector technologies and manufacturing services to pharmaceutical manufacturers; and active pharmaceutical ingredients (API), and finished dose formulation and manufacturing services. The company offers its products to pharmaceutical companies in the US, Europe, and other parts of the world through its subsidiaries and distributors. Consort Medical is headquartered in Hertfordshire, England, the UK.

Consort Medical plc (CSRT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Consort Medical plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Consort Medical plc, Medical Devices Deals, 2012 to YTD 2018 9

Consort Medical plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Consort Medical plc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Precision Ocular Raises USD20.5 Million in Series A Financing 11

Precision Ocular Raises USD19.4 Million in Venture Financing 13

Partnerships 15

SteadyMed Therapeutics Enters into Co-Development Agreement with Bespak 15

Aesica Enters Into Co-Development Agreement With University Of Nottingham For Amide Bond Synthesis 16

Licensing Agreements 17

Consort Medical Enter into Development Agreement with Opiant Pharma 17

Equity Offering 18

Consort Medical Raises USD160.6 Million in Rights Issue of Shares 18

Acquisition 20

Consort Medical Acquires Aesica Holdco for USD378.5 million 20

Consort Medical plc-Key Competitors 21

Consort Medical plc-Key Employees 22

Consort Medical plc-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 25

Financial Announcements 25

Jun 14, 2018: Consort Medical delivered another year of good growth in revenue and profit 25

Dec 05, 2017: Consort Medical: Interim results 28

Jun 15, 2017: Consort Medical: Full year results 29

Corporate Communications 30

Nov 06, 2018: Consort Medical announces its board change 30

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31


List Of Figure

List of Figures

Consort Medical plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Consort Medical plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Consort Medical plc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Consort Medical plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Consort Medical plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Consort Medical plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Consort Medical plc, Deals By Therapy Area, 2012 to YTD 2018 8

Consort Medical plc, Medical Devices Deals, 2012 to YTD 2018 9

Consort Medical plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Precision Ocular Raises USD20.5 Million in Series A Financing 11

Precision Ocular Raises USD19.4 Million in Venture Financing 13

SteadyMed Therapeutics Enters into Co-Development Agreement with Bespak 15

Aesica Enters Into Co-Development Agreement With University Of Nottingham For Amide Bond Synthesis 16

Consort Medical Enter into Development Agreement with Opiant Pharma 17

Consort Medical Raises USD160.6 Million in Rights Issue of Shares 18

Consort Medical Acquires Aesica Holdco for USD378.5 million 20

Consort Medical plc, Key Competitors 21

Consort Medical plc, Key Employees 22

Consort Medical plc, Other Locations 23

Consort Medical plc, Subsidiaries 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Consort Medical plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.